Cardiac MRI plays an important role in the evaluation of cardiovascular diseases (CVDs),
including ischemic heart disease, cardiomyopathy, valvular disease, congenital disease …

Background There is no consensus regarding the relative prognostic value of cardiac MRI
and fluorodeoxyglucose (FDG) PET in cardiac sarcoidosis. Purpose To perform a systematic …

Purpose To compare combined cardiac fluorine 18 (18F) fluorodeoxyglucose (FDG)
PET/MRI with standard-of-care evaluation using cardiac MRI, 18F-FDG PET/CT, and SPECT …

Myocarditis is defined as a non-ischemic inflammatory disease of the myocardium. It
remains a challenge to diagnose given non-specific symptoms and lack of specific blood …

Background Many individuals have persistent cardiac symptoms after mild COVID-19
infection. However, studies assessing the relationship between symptoms and cardiac …

Globally, over 650 million people have had COVID‐19 due to infection with the SARS‐Cov‐
2 virus. Cardiac complications in the acute infectious and early recovery phase were …

Cardiovascular magnetic resonance (CMR) is a proven imaging modality for informing
diagnosis and prognosis, guiding therapeutic decisions, and risk stratifying surgical …

Background Parametric mapping sequences in cardiovascular magnetic resonance (CMR)
allow for non-invasive myocardial tissue characterization. However quantitative myocardial …

Since its inaugural issue in 2019, Radiology: Cardiothoracic Imaging has disseminated the
latest scientific advances and technical developments in cardiac, vascular, and thoracic …

Purpose To evaluate potential cardiac sequelae of COVID-19 vaccination at 2-month follow-
up and to relate cardiac symptoms to myocardial tissue changes at fluorodeoxyglucose …